JMC Office of CME
|
Recent Events
- Examine and implement into practice the new Guidelines from the Third Consensus Development Conference on the Management of Asymptomatic Primary Hyperparathyroidism.
- Analyze the indications for newly developed pharmacotherapy agents and identify their utility in treating the hyperparathyroid patient.
- Differentiate secondary hyperparathyroidism due to vitamin D deficiency from primary hyperparathyroidism on the basis of serological testing and develop a treatment strategy.
- Identify the causes of secondary hyperparathyroidism and integrate into practice established protocols for the treatment of the specific causes, e.g., vitamin D deficiency, celiac disease, and renal failure.
- Critique the new guidelines for the surgical treatment of parathyroid gland disorders and select the appropriate surgical treatment option based on cure and completion rates.
- Evaluate and integrate into practice various operative adjuncts to assist in surgery including intraoperative PTH monitoring, gamma probe with preoperative sestamibi injection, and intraoperative laryngeal nerve monitoring, venous sampling and ultrasonography.
- Based on the surgical protocols, identify patients for surgery, order optimal preoperative evaluations and discuss potential complications with patients.
- Assess their individual practice in light of the information and discussions during the course, and identify specific strategies to implement as part of a continuing improvement process for their practices.
|
Parathyroid 2012: Advances in the Diagnosis and Treatment of Parathyroid Disease
Friday, November 16, 2012 Bluemle Life Sciences Building - Thomas Jefferson University Campus 233 South 10th Street Philadelphia PA, 19107 |
Parathyroid 2012: New Advances in the Diagnosis and Treatment of Parathyroid Disease participants will learn up-to-date algorithms for the diagnosis and treatment of parathyroid disease from internationally renowned keynote speakers who have helped to define these guidelines. A unique panel of expert's format will permit key questions to be posed to nationally prominent endocrinologists & endocrine surgeons in search of consensus strategies. Moreover, this gathering of specialists from across medical and surgical disciplines offers the opportunity for appreciating varying perspectives on the optimal delivery of patient care. The combined format of live debate and didactic presentations will allow participants to observe and question faculty practitioners as they deal with real patient problems, and demonstrate how to apply new information and evidence based guidelines into their practices. This course will evaluate the recent advances in diagnostic and therapeutic approaches to parathyroid disease that have altered traditional management paradigms. New guidelines and optimal surgical protocols will be introduced, which are intended to enhance the current knowledge, allowing health professionals to appropriately refer patients for surgery and order optimal pre- and post-operative evaluations for patients. Featured Keynote Speakers:
John P. Bilezikian, MD
Brendan C. Stack Jr. MD, FACS, FACE
ACCREDITATION INFORMATION
Faculty Disclosure Statement:
Learning Objectives: Jefferson Medical College designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity. Download Agenda | Download Brochure | Exhibitors | Hotel Information Online registration is now closed. Individuals interested in attending can register on-site for this conference. | |
Presented by
-
The Division of Endocrinology, Diabetes and Metabolic Diseases provides comprehensive care for patients with Type I and Type II diabetes mellitus, obesity and thyroid nodules and goiters. Expert evaluation and management of other hormonal and glandular disorders involving the thyroid, pituitary, parathyroid and adrenal glands, as well as osteoporosis, other bone disorders and calcium metabolism and disorders of cholesterol and triglyceride metabolism.
- make transformational discoveries of the cellular and molecular biology of the malignant process and the individual's and society's response to it
- effectively translate the latest research discoveries and clinical trials to provide the highest quality of care to all patients including those of diverse ethnic and racial populations
- provide expert and humanitarian care to cancer patients, their families, and those at risk
The Department of Otolaryngology - Head and Neck Surgery at Jefferson University Hospital is the regional leader in minimally invasive thyroid and parathyroid surgery. The department serves a large and varied patient community, including children, and features specialized centers and programs dedicated to hearing and balance disorders, taste and smell disorders, reconstructive and facial plastic surgery, and, uniquely, the care of the professional performing or voice-over artist. For our multidisciplinary approach to head and neck cancer, we collaborate closely with Jefferson University Hospital's Kimmel Cancer Center and Center for Integrative Medicine
The Kimmel Cancer Center (KCC) was founded in 1991 and is one of a select group of cancer centers in the nation designated by the National Cancer Institute. Today, the KCC has approximately 150 members that include physicians and scientists dedicated to discovery and development of novel approaches for cancer treatment. The mission of the Kimmel Cancer Center, a National Cancer Institute-designated cancer center, is to: